Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition
NCT05532306
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Ribavirin 400 mg film coated tablet (1*400mg)
DRUG:
Copegus® 200 mg film coated tablet (2*200mg)
Sponsor
Future University in Egypt